Tissue engineering for the repair of cartilage defects;Réparation du cartilage articulaire par ingénierie tissulaire

Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur

Volumn 94, Issue 8 SUPPL., 2008, Pages 383-393

  Hannouche, D ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Paris university   (France)

Author keywords

Biomaterials; Bioreactor; Cartilage; Cell therapy; Mesenchymal stem cells; Tissue engineering

Indexed keywords

EID: 56849093989     PISSN: 00351040     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rco.2008.09.004     Document Type: Review

References (97)

1. Buckwalter J.A. Articular cartilage injuries. Clin Orthop Relat Res 402 (2002) 21-37
2. Indelicato P.A., and Bittar E.S. A perspective of lesions associated with ACL insufficiency of the knee. A review of 100 cases. Clin Orthop Relat Res 198 (1985) 77-80
3. Shelbourne K.D., Jari S., and Gray T. Outcome of untreated traumatic articular cartilage defects of the knee: a natural history study. J Bone Joint Surg Am 85-A Suppl. 2 (2003) 8-16
4. Carney S.L., and Muir H. The structure and function of cartilage proteoglycans. Physiol Rev 68 3 (1988) 858-910
5. Bruckner P., and van der Rest M. Structure and function of cartilage collagens. Microsc Res Tech 28 5 (1994) 378-384
6. Heinegard D., Hultenby K., Oldberg A., Reinholt F., and Wendel M. Macromolecules in bone matrix. Connect Tissue Res 21 1-4 (1989) 3-11 discussion 2-4
7. Mendler M., Eich-Bender S.G., Vaughan L., Winterhalter K.H., and Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX and XI. J Cell Biol 108 1 (1989) 191-197
8. Roughley P.J., and Lee E.R. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech 28 5 (1994) 385-397
9. Eble J.A., Kassner A., Niland S., Morgelin M., Grifka J., and Grassel S. Collagen XVI harbors an integrin alpha 1beta 1 recognition site in its C-terminal domains. J Biol Chem (2006)
10. Font B., Eichenberger D., Goldschmidt D., Boutillon M.M., and Hulmes D.J. Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis-critical roles for disulphide bonding and the C-terminal region. Eur J Biochem 254 3 (1998) 580-587
11. Eyre D. Collagen of articular cartilage. Arthritis Res 4 1 (2002) 30-35
12. Wagener R., Ehlen H.W., Ko Y.P., Kobbe B., Mann H.H., Sengle G., et al. The matrilins-adaptor proteins in the extracellular matrix. FEBS Lett 579 15 (2005) 3323-3329
13. Guilak F., Alexopoulos L.G., Upton M.L., Youn I., Choi J.B., Cao L., et al. The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage. Ann N Y Acad Sci 1068 (2006) 498-512
14. Knudson C.B., and Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 12 2 (2001) 69-78
15. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17 12 (1995) 1039-1048
16. Bromme D., and Kaleta J. Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr Pharm Des 8 18 (2002) 1639-1658
17. Bramono D.S., Richmond J.C., Weitzel P.P., Kaplan D.L., and Altman G.H. Matrix metalloproteinases and their clinical applications in orthopaedics. Clin Orthop Relat Res 428 (2004) 272-285
18. Jones G.C., and Riley G.P. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther 7 4 (2005) 160-169
19. Heathfield T.F., Onnerfjord P., Dahlberg L., and Heinegard D. Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem 279 8 (2004) 6286-6295
20. Cheung H.S., Cottrell W.H., Stephenson K., and Nimni M.E. In vitro collagen biosynthesis in healing and normal rabbit articular cartilage. J Bone Joint Surg Am 60 8 (1978) 1076-1081
21. Shapiro F., Koide S., and Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75 4 (1993) 532-553
22. Steadman J.R., Rodkey W.G., and Briggs K.K. Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. J Knee Surg 15 3 (2002) 170-176
23. Wilson W.J., and Jacobs J.E. Patellar graft for severely depressed comminuted fractures of the lateral tibial condyle. J Bone Joint Surg Am 34-A 2 (1952) 436-442
24. Yamashita F., Sakakida K., Suzu F., and Takai S. The transplantation of an autogeneic osteochondral fragment for osteochondritis dissecans of the knee. Clin Orthop Relat Res 201 (1985) 43-50
25. Hangody L., Kish G., Karpati Z., Szerb I., and Udvarhelyi I. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg Sports Traumatol Arthrosc 5 4 (1997) 262-267
26. LaPrade R.F., and Botker J.C. Donor-site morbidity after osteochondral autograft transfer procedures. Arthroscopy 20 7 (2004) e69-e73
27. Huntley J.S., Simpson A.H., and Hall A.C. Use of non-degenerate human osteochondral tissue and confocal laser scanning microscopy for the study of chondrocyte death at cartilage surgery. Eur Cell Mater 9 (2005) 13-22
28. Peterson L., Menche D., and Grande D. Chondrocyte transplantation: an experimental model in the rabbit. Trans Orthop Res Soc 9 (1984) 218
29. Grande D.A., Singh I.J., and Pugh J. Healing of experimentally produced lesions in articular cartilage following chondrocyte transplantation. Anat Rec 218 2 (1987) 142-148
30. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 14 (1994) 889-895
31. Peterson L., Brittberg M., Kiviranta I., Akerlund E.L., and Lindahl A. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30 1 (2002) 2-12
32. Henderson I., Francisco R., Oakes B., and Cameron J. Autologous chondrocyte implantation for treatment of focal chondral defects of the knee-a clinical, arthroscopic. MRI and histologic evaluation at 2 years. Knee 12 3 (2005) 209-216
33. Minas T. Autologous chondrocyte implantation for focal chondral defects of the knee. Clin Orthop Relat Res 391 Suppl. (2001) S349-S361
34. Roberts S., McCall I.W., Darby A.J., Menage J., Evans H., Harrison P.E., et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther 5 1 (2003) R60-R73
35. Briggs T.W., Mahroof S., David L.A., Flannelly J., Pringle J., and Bayliss M. Histological evaluation of chondral defects after autologous chondrocyte implantation of the knee. J Bone Joint Surg Br 85 7 (2003) 1077-1083
36. Browne J.E., Anderson A.F., Arciero R., Mandelbaum B., Moseley Jr. J.B., Micheli L.J., et al. Clinical outcome of autologous chondrocyte implantation at 5 years in US subjects. Clin Orthop Relat Res 436 (2005) 237-245
37. Whittaker J.P., Smith G., Makwana N., Roberts S., Harrison P.E., Laing P., et al. Early results of autologous chondrocyte implantation in the talus. J Bone Joint Surg Br 87 2 (2005) 179-183
38. Ferruzzi A., Calderoni P., Grigolo B., and Gualtieri G. Autologous chondrocytes implantation: indications and results in the treatment of articular cartilage lesions of the knee. Chir Organi Mov 89 2 (2004) 125-134
39. Peterson L., Minas T., Brittberg M., and Lindahl A. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at 2 to 10 years. J Bone Joint Surg Am 85-A Suppl. 2 (2003) 17-24
40. Robert H., Bahuaud J., Kerdiles N., Passuti N., Capelli M., Pujol J.P., et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation: a review of 28 cases. Rev Chir Orthop 93 7 (2007) 701-709
41. Peterson L., Minas T., Brittberg M., Nilsson A., Sjogren-Jansson E., and Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 374 (2000) 212-234
42. Knutsen G., Engebretsen L., Ludvigsen T.C., Drogset J.O., Grontvedt T., Solheim E., et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 86-A 3 (2004) 455-464
43. Horas U., Pelinkovic D., Herr G., Aigner T., and Schnettler R. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am 85-A 2 (2003) 185-192
44. Bentley G., Biant L.C., Carrington R.W., Akmal M., Goldberg A., Williams A.M., et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br 85 2 (2003) 223-230
45. Breinan H.A., Minas T., Hsu H.P., Nehrer S., Sledge C.B., and Spector M. Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model. J Bone Joint Surg Am 79 10 (1997) 1439-1451
46. Vasara A.I., Hyttinen M.M., Pulliainen O., Lammi M.J., Jurvelin J.S., Peterson L., et al. Immature porcine knee cartilage lesions show good healing with or without autologous chondrocyte transplantation. Osteoarthritis Cartilage 14 10 (2006) 1066-1074
47. Waldman S.D., Grynpas M.D., Pilliar R.M., and Kandel R.A. The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage. J Orthop Res 21 1 (2003) 132-138
48. Grigolo B., Roseti L., De Franceschi L., Piacentini A., Cattini L., Manfredini M., et al. Molecular and immunohistological characterization of human cartilage two years following autologous cell transplantation. J Bone Joint Surg Am 87 1 (2005) 46-57
49. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10 6 (2002) 432-463
50. Bachmann G., Basad E., Lommel D., and Steinmeyer J. MRI in the follow-up of matrix-supported autologous chondrocyte transplantation (MACI) and microfracture. Radiologe 44 8 (2004) 773-782
51. Terada S., Yoshimoto H., Fuchs J.R., Sato M., Pomerantseva I., Selig M.K., et al. Hydrogel optimization for cultured elastic chondrocytes seeded onto a polyglycolic acid scaffold. J Biomed Mater Res A 75 4 (2005) 907-916
52. Malda J., van Blitterswijk C.A., Grojec M., Martens D.E., Tramper J., and Riesle J. Expansion of bovine chondrocytes on microcarriers enhances redifferentiation. Tissue Eng 9 5 (2003) 939-948
53. Boyan B.D., Hummert T.W., Dean D.D., and Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17 2 (1996) 137-146
54. Maroudas N.G. Sulphonated polystyrene as an optimal substratum for the adhesion and spreading of mesenchymal cells in monovalent and divalent saline solutions. J Cell Physiol 90 3 (1977) 511-519
55. Selmi T.A., Verdonk P., Chambat P., Dubrana F., Potel J.F., Barnouin L., et al. Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at 2 years. J Bone Joint Surg Br 90 5 (2008) 597-604
56. Patti A.M., Gabriele A., Vulcano A., Ramieri M.T., and Della Rocca C. Effect of hyaluronic acid on human chondrocyte cell lines from articular cartilage. Tissue Cell 33 3 (2001) 294-300
57. Nehrer S., Domayer S., Dorotka R., Schatz K., Bindreiter U., and Kotz R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 57 1 (2006) 3-8
58. Benya P.D., and Padilla S.R. Modulation of the rabbit chondrocyte phenotype by retinoic acid terminates type II collagen synthesis without inducing type I collagen: the modulated phenotype differs from that produced by subculture. Dev Biol 118 1 (1986) 296-305
59. Dozin B., Malpeli M., Camardella L., Cancedda R., and Pietrangelo A. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol 21 5 (2002) 449-459
60. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., and Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 2 (1968) 230-247
61. Weissman I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287 5457 (2000) 1442-1446
62. Petite H., and Hannouche D. Marrow stromal stem cells for repairing the skeleton. Biotechnol Genet Eng Rev 19 (2002) 83-101
63. Bruder S.P., Jaiswal N., and Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64 2 (1997) 278-294
64. Bruder S.P., Jaiswal N., Ricalton N.S., Mosca J.D., Kraus K.H., and Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 355 Suppl. (1998) S247-S256
65. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11 7-8 (2005) 1198-1211
66. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
67. Huang J.I., Kazmi N., Durbhakula M.M., Hering T.M., Yoo J.U., and Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23 6 (2005) 1383-1389
68. Shirasawa S., Sekiya I., Sakaguchi Y., Yagishita K., Ichinose S., and Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 97 1 (2006) 84-97
69. Kuwana M., Okazaki Y., Kodama H., Izumi K., Yasuoka H., Ogawa Y., et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74 5 (2003) 833-845
70. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., and Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 5 (2004) 1669-1675
71. De Angelis L., Berghella L., Coletta M., Lattanzi L., Zanchi M., Cusella-De Angelis M.G., et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147 4 (1999) 869-878
72. Miura M., Gronthos S., Zhao M., Lu B., Fisher L.W., Robey P.G., et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100 10 (2003) 5807-5812
73. Lazarus H.M., Haynesworth S.E., Gerson S.L., and Caplan A.I. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 6 5 (1997) 447-455
74. Haynesworth S.E., Goshima J., Goldberg V.M., and Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 13 1 (1992) 81-88
75. Black I.B., and Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol Dis 27 3 (2001) 632-636
76. Chen L.B., Jiang X.B., and Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10 20 (2004) 3016-3020
77. de Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., and Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 19 5 (2000) 389-394
78. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., and Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238 1 (1998) 265-272
79. Ponticiello M.S., Schinagl R.M., Kadiyala S., and Barry F.P. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52 2 (2000) 246-255
80. Caterson E.J., Nesti L.J., Li W.J., Danielson K.G., Albert T.J., Vaccaro A.R., et al. Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam. J Biomed Mater Res 57 3 (2001) 394-403
81. Oshima Y., Watanabe N., Matsuda K., Takai S., Kawata M., and Kubo T. Fate of transplanted bone-marrow-derived mesenchymal cells during osteochondral repair using transgenic rats to simulate autologous transplantation. Osteoarthritis Cartilage 12 10 (2004) 811-817
82. Angele P., Kujat R., Nerlich M., Yoo J., Goldberg V., and Johnstone B. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng 5 6 (1999) 545-554
83. Li W.J., Tuli R., Okafor C., Derfoul A., Danielson K.G., Hall D.J., et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26 6 (2005) 599-609
84. Hunziker E.B. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?. Osteoarthritis Cartilage 7 1 (1999) 15-28
85. Martin I., Padera R.F., Vunjak-Novakovic G., and Freed L.E. In vitro differentiation of chick embryo bone marrow stromal cells into cartilaginous and bone-like tissues. J Orthop Res 16 2 (1998) 181-189
86. Martin I., Shastri V.P., Padera R.F., Langer R., Vunjak-Novakovic G., and Freed L.E. Bone marrow stromal cell differentiation on porous polymer scaffolds. Trans Orthop Res Soc 24 (1999) 57
87. Vunjak-Novakovic G., Meinel L., Altman G., and Kaplan D. Bioreactor cultivation of osteochondral grafts. Orthod Craniofac Res 8 3 (2005) 209-218
88. Wendt D., Jakob M., and Martin I. Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturing. J Biosci Bioeng 100 5 (2005) 489-494
89. Carver S.E., and Heath C.A. Influence of intermittent pressure, fluid flow, and mixing on the regenerative properties of articular chondrocytes. Biotechnol Bioeng 65 3 (1999) 274-281
90. Darling E.M., and Athanasiou K.A. Articular cartilage bioreactors and bioprocesses. Tissue Eng 9 1 (2003) 9-26
91. Hannouche D., Terai H., Fuchs J.R., Terada S., Zand S., Nasseri B.A., et al. Engineering of implantable cartilaginous structures from bone marrow derived mesenchymal stem cells. Tissue Eng 13 (2007) 87-99
92. Fuchs J.R., Hannouche D., Terada S., Zand S., Vacanti J.P., and Fauza D.O. Cartilage engineering from ovine ombilical cord blood mesenchymal progenitor cells. Stem Cells 23 (2005) 958-964
93. Ikenoue T., Trindade M.C., Lee M.S., Lin E.Y., Schurman D.J., Goodman S.B., et al. Mechanoregulation of human articular chondrocyte aggrecan and type II collagen expression by intermittent hydrostatic pressure in vitro. J Orthop Res 21 1 (2003) 110-116
94. Ma H.L., Chen T.H., Low-Tone Ho L., and Hung S.C. Neocartilage from human mesenchymal stem cells in alginate: implied timing of transplantation. J Biomed Mater Res A 74 3 (2005) 439-446
95. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76 4 (1994) 579-592
96. Wakitani S., Mitsuoka T., Nakamura N., Toritsuka Y., Nakamura Y., and Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13 5 (2004) 595-600
97. Mackenzie T.C., and Flake A.W. Multilineage differentiation of human MSC after in utero transplantation. Cytotherapy 3 5 (2001) 403-405